SCOTTSDALE, Ariz., Nov. 14, 2016 -- Annexus Ventures, a venture capital firm focused on making early-stage investments in InsureTech and FinTech companies, announced a new strategic investment in Michigan-based developer RepPro, creators of the simplified digital application experience for financial professionals.
|
|||
“RepPro’s platform provides the foundation for a quick and easy experience that allows advisors to digitally complete and sign brokerage, insurance or annuity applications, as well as distribution specific and dynamic Best Interest Contract Exemption paperwork,” said Jim Richards, Annexus Ventures Managing Partner.
Unlike any of the legacy systems in the market today, RepPro can completely remove the forms integration workload from the carrier or financial institution and be fully deployed in a matter of weeks, not months.
"RepPro has realized nearly 300% faster adoption than the competition,” said Patrick Kelly, Founder and CEO at RepPro. “These high adoption rates create an opportunity for insurance carriers and other institutions to yield tremendous cost savings by increasing accuracy, decreasing processing time and providing a DOL-compliant process.”
Annexus Ventures is actively developing partnerships with leading technology companies. This is the second FinTech investment announcement by Annexus Ventures in the last two weeks.
About Annexus Ventures
Annexus Ventures is a venture capital firm focused on making early-stage investments in InsureTech, FinTech and software companies. Annexus Ventures delivers a wealth of financial industry expertise, mature business networks and capital support to accelerate promising technology companies. For more information, please visit www.AnnexusVentures.com.
Media Contact Jim Richards, Managing Partner Annexus Ventures [email protected]


Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Washington Post Publisher Will Lewis Steps Down After Layoffs
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



